Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of Prevention of Ovarian Cancer by Oral Contraceptives
NCT02155777Phase 1Completed
- Sponsor
- University of Michigan
- Start
- Jun 2014
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, open-label trial of norethindrone + ethinyl estradiol in ovarian cancer (2 arms), sponsored by University of Michigan. Primary endpoint: Differences in cell proliferation as measured by Ki67 immunohistochemical analysis in the fallopian tube fimbriae. Started Jun 2014; status: completed.
02
Drugs
norethindrone + ethinyl estradiol
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT02155777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02155777.